Tourmaline Bio Performance

TRMLDelisted Stock

47.98 0.00 0.00%

Tourmaline Bio has a performance score of 24 on a scale of 0 to 100. The entity has a beta of 1.48, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Tourmaline Bio will likely underperform. Tourmaline Bio right now has a risk of 0.0462%. Please validate Tourmaline Bio treynor ratio, semi variance, as well as the relationship between the Semi Variance and day median price , to decide if Tourmaline Bio will be following its existing price patterns.

Risk-Adjusted Performance

Solid

Weak

Strong

Compared to the overall equity markets, risk-adjusted returns on investments in Tourmaline Bio are ranked lower than 24 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent primary indicators, Tourmaline Bio is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors. ...more

	Begin Period Cash Flow	141 M
	Total Cashflows From Investing Activities	-194.3 M

Tourmaline Bio Relative Risk vs. Return Landscape

If you would invest 4,787 in Tourmaline Bio on October 10, 2025 and sell it today you would earn a total of 11.00 from holding Tourmaline Bio or generate 0.23% return on investment over 90 days. Tourmaline Bio is currently generating 0.0144% in daily expected returns and assumes 0.0462% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Tourmaline, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.

Expected Return

Risk

Given the investment horizon of 90 days Tourmaline Bio is expected to generate 8.66 times less return on investment than the market. But when comparing it to its historical volatility, the company is 15.61 times less risky than the market. It trades about 0.31 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.17 of returns per unit of risk over similar time horizon.

Tourmaline Bio Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Tourmaline Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Tourmaline Bio, and traders can use it to determine the average amount a Tourmaline Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.311

Best Portfolio	Best Equity
Good Returns
Average Returns
Small Returns
Cash	Small Risk	Average Risk	High Risk	Huge Risk
TRML

Based on monthly moving average Tourmaline Bio is performing at about 24% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tourmaline Bio by adding it to a well-diversified portfolio.

Tourmaline Bio Fundamentals Growth

Tourmaline Stock prices reflect investors' perceptions of the future prospects and financial health of Tourmaline Bio, and Tourmaline Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Tourmaline Stock performance.

	Return On Equity	-0.3
	Return On Asset	-0.21
	Current Valuation	993.63 M
	Shares Outstanding	25.69 M
	Price To Book	4.75 X
	EBITDA	(89.73 M)
	Total Debt	244 K
	Book Value Per Share	10.09 X
	Cash Flow From Operations	(77.26 M)
	Earnings Per Share	(3.44) X
	Total Asset	309 M
	Retained Earnings	(135.26 M)

About Tourmaline Bio Performance

By examining Tourmaline Bio's fundamental ratios, stakeholders can obtain critical insights into Tourmaline Bio's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Tourmaline Bio is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.

Things to note about Tourmaline Bio performance evaluation

Checking the ongoing alerts about Tourmaline Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Tourmaline Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

	Tourmaline Bio is not yet fully synchronised with the market data
	Tourmaline Bio has a very high chance of going through financial distress in the upcoming years
	Net Loss for the year was (73.21 M) with profit before overhead, payroll, taxes, and interest of 0.
	Tourmaline Bio generates negative cash flow from operations
	Over 89.0% of the company shares are owned by institutional investors

Evaluating Tourmaline Bio's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Tourmaline Bio's stock performance include:

Analyzing Tourmaline Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Tourmaline Bio's stock is overvalued or undervalued compared to its peers.
Examining Tourmaline Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
Evaluating Tourmaline Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Tourmaline Bio's management team can help you assess the Company's leadership.
Pay attention to analyst opinions and ratings of Tourmaline Bio's stock. These opinions can provide insight into Tourmaline Bio's potential for growth and whether the stock is currently undervalued or overvalued.

It's essential to remember that evaluating Tourmaline Bio's stock performance is not an exact science, and many factors can impact Tourmaline Bio's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Consideration for investing in Tourmaline Stock

If you are still planning to invest in Tourmaline Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tourmaline Bio's history and understand the potential risks before investing.

	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	Volatility Analysis Get historical volatility and risk analysis based on latest market data
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC